- Joined
- Dec 3, 2017
- Messages
- 26,290
- Reaction score
- 16,775
- Gender
- Male
- Political Leaning
- Progressive
Vaccine by Nov. 3? Halted study explains just how unlikely
WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.
AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer’s illness is a side effect or a coincidence.
“This ought to be reassuring,” NIH Director Dr. Francis Collins said before a Senate committee. “When we say we are going to focus first on safety and make no compromises, here is Exhibit A of how that is happening in practice.”
Scientists have been scrambling to develop a vaccine against the coronavirus since the outbreak began, and the U.S. has launched the world’s largest studies — final-stage testing of three leading candidates, with three more trials set to come soon that will each recruit 30,000 test subjects.
======================================================================
Seven or eight months to develop a safe & effective vaccine by Nov. 3 is science fiction. The coroinavirus family (MERS, SARS, COVID-19) are highly evolved & very complex, with tricks for defeating a host's immune system. And antibodies against COVID-19 are not long-lived, possibly requiring repeated revaccination. And only a small fraction of the population is going to get the first shots, leaving big gaps in immune coverage.
WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.
AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer’s illness is a side effect or a coincidence.
“This ought to be reassuring,” NIH Director Dr. Francis Collins said before a Senate committee. “When we say we are going to focus first on safety and make no compromises, here is Exhibit A of how that is happening in practice.”
Scientists have been scrambling to develop a vaccine against the coronavirus since the outbreak began, and the U.S. has launched the world’s largest studies — final-stage testing of three leading candidates, with three more trials set to come soon that will each recruit 30,000 test subjects.
======================================================================
Seven or eight months to develop a safe & effective vaccine by Nov. 3 is science fiction. The coroinavirus family (MERS, SARS, COVID-19) are highly evolved & very complex, with tricks for defeating a host's immune system. And antibodies against COVID-19 are not long-lived, possibly requiring repeated revaccination. And only a small fraction of the population is going to get the first shots, leaving big gaps in immune coverage.